Intercept Pharmaceuticals OverviewIntercept Pharmaceuticals Operating Income
Operating Income for ICPT.
Quarterly Operating Income
$-4619000.00
↓ 54.47% YoY
As of Sep 30, 2023
Annual Operating Income (TTM)
$-77807000.00
↑ 42.39% YoY
Trailing 12 months ending Sep 30, 2023